Open AccessSerum potassium changes due to concomitant ACEI/ARB and spironolactone therapy: A systematic review and meta-analysis
Author(s) -
Lorenzo VillaZapata,
Briggs S Carhart,
John R. Horn,
Philip D. Hansten,
Vignesh Subbian,
Sheila M. Gephart,
Malinda S. Tan,
Andrew Romero,
Daniel C. Malone
Publication year - 2021
Publication title -
american journal of health-system pharmacy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.487
H-Index - 96
eISSN - 1535-2900
pISSN - 1079-2082
DOI - 10.1093/ajhp/zxab215
Subject(s) - spironolactone , medicine , meta analysis , publication bias , combination therapy , pharmacology , endocrinology , aldosterone
To provide evidence of serum potassium changes in individuals taking angiotensin-converting enzyme inhibitors (ACEIs) and/or angiotensin receptor blockers (ARBs) concomitantly with spironolactone compared to ACEI/ARB therapy alone.